examworks group inc
(EXAM:New York Consolidated)
examworks group inc (EXAM) Snapshot
|
Open
$18.13
|
Previous Close
$18.32
|
|
|
Day High
$18.53
|
Day Low
$18.00
|
|
|
52 Week High
05/17/13 - $19.72
|
52 Week Low
06/4/12 - $10.81
|
|
|
Market Cap
648.5M
|
Average Volume 10 Days
172.1K
|
|
|
EPS TTM
$-0.37
|
Shares Outstanding
35.1M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
examworks group inc (EXAM) Related Businessweek News
No Related Businessweek News Foundexamworks group inc (EXAM) Details
ExamWorks Group, Inc., together with its subsidiaries, provides independent medical examinations (IME), peer and bill reviews, and related services in the United States, Canada, the United Kingdom, and Australia. Its IME services are used by clients to confirm the veracity of claims by sick or injured individuals for workers’ compensation, automotive, personal injury liability, and disability insurance coverage. The company also offers peer review services, including medical record reviews, nurse file reviews, and utilization reviews by members of its medical panel to provide medical opinion of a claimant’s condition and treatment; bill review services, such as physician and hospital bill reviews, and surgical cost estimates; and other IME related services comprising litigation support, medical record retrieval, administrative support services, and managed technology services. ExamWorks Group, Inc. provides its services through its medical panel of independently contracted physicians and other medical providers. It serves property and casualty insurance carriers, law firms, third-party claim administrators, government agencies, and state funds. The company was incorporated in 2007 and is headquartered in Atlanta, Georgia.
examworks group inc (EXAM) Top Compensated Officers
examworks group inc (EXAM) Key Developments
ExamWorks Group, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported revenues of $148,703,000 compared to $123,738,000 a year ago. Income from operations was $1,736,000 compared to loss from operations of $92,000 a year ago. Loss before income taxes was $5,794,000 compared to $6,665,000 a year ago. Net loss was $3,592,000 or $0.10 per basic and diluted share compared to $4,323,000 or $0.13 per basic and diluted share a year ago. Adjusted EBITDA was $23,005,000 compared to $18,829,000 a year ago. Net cash used in operating activities was $1,110,000 compared to net cash provided by operating activities of $4,799,000 a year ago. Purchases of equipment and leasehold improvements, net was $1,770,000 compared to $552,000 a year ago. The increase in revenue was primarily due to acquisitions completed in 2012 and growth in its U.K. business. On a pro forma basis, revenues were $148.7 million, an increase of 6.0% over the $140.3 million in pro forma revenues in the first quarter of 2012. The company provided the following business outlook for the full year and the second quarter of 2013. For the second quarter 2013 reported revenues are expected to range between $150 million and $154 million. Second quarter 2013 reported adjusted EBITDA margins are expected to range between 15.5% and 16.0% of reported revenues. The company reaffirmed its previously stated guidance; full year 2013 reported revenues are expected to increase organically by 5-7% from its 2012 pro forma revenues of approximately $574 million, excluding the effects of currency. This revenue increase does not include the potential revenue contribution from acquisitions that it may close in 2013. Full year 2013 adjusted EBITDA margins are expected to range between 15.5% and 16.5% of reported revenues. Income tax effective rate to be approximately 35%. Cash flow from operations to be approximately $40 million.
ExamWorks Group, Inc. announced that they will report Q1, 2013 results After-Market on May 08, 2013
ExamWorks Group, Inc., Q1 2013 Earnings Call, May 08, 2013
| Recently Viewed | |||
| EXAM:US | $18.50 USD | +0.18 | |
| Company | Last | Change | |
| No competitor information is available for EXAM. | |||
| View Industry Companies | |||
Industry Analysis
EXAM
Industry Average
| Valuation | EXAM | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 1.2x |
|
| Price/Book | 2.6x |
|
| Price/Cash Flow | 13.9x |
|
| TEV/Sales | 0.5x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact EXAMWORKS GROUP INC, please visit www.examworks.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








